Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-10 09:48 am Sale |
2022-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 5,921,695 3.920% |
-5,134,534 (-46.44%) |
Filing History |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
BLACKROCK INC BLK |
4,755,365 3.300% |
-4,995,912 (-51.23%) |
Filing History |
| 2022-04-11 1:58 pm Sale |
2022-03-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
STATE STREET CORP STT |
2,619,477 1.840% |
-13,495,065 (-83.74%) |
Filing History |
| 2022-03-11 2:13 pm Unchanged |
2021-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
BLACKROCK INC BLK |
9,751,277 7.500% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:59 pm Sale |
2021-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
Palo Alto Investors LP | 3,997,826 3.080% |
-471,585 (-10.55%) |
Filing History |
| 2022-02-11 08:18 am Purchase |
2021-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 11,056,229 7.840% |
1,147,989 (+11.59%) |
Filing History |
| 2022-02-11 07:57 am Purchase |
2021-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
STATE STREET CORP STT |
16,114,542 12.400% |
5,655,198 (+54.07%) |
Filing History |
| 2022-02-09 3:43 pm Sale |
2021-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
The Vanguard Group | 10,115,101 7.780% |
-2,179,790 (-17.73%) |
Filing History |
| 2022-02-08 5:05 pm Purchase |
2021-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
BLACKROCK INC BLK |
9,751,277 7.500% |
2,890,045 (+42.12%) |
Filing History |
| 2021-10-12 09:29 am Purchase |
2021-09-30 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
The Vanguard Group | 12,294,891 10.380% |
5,907,337 (+92.48%) |
Filing History |
| 2021-06-10 10:13 am Purchase |
2021-05-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
STATE STREET CORP STT |
10,459,344 10.000% |
566,467 (+5.73%) |
Filing History |
| 2021-04-12 11:52 am Sale |
2021-03-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
STATE STREET CORP STT |
9,892,877 9.460% |
-4,642,995 (-31.94%) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
Citadel Advisors LLC | 2,194,035 2.100% |
-1,198,589 (-35.33%) |
Filing History |
| 2021-02-16 4:29 pm Sale |
2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
Palo Alto Investors LP | 4,469,411 5.060% |
-586,875 (-11.61%) |
Filing History |
| 2021-02-16 4:11 pm Sale |
2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
Redmile Group LLC | 0 0.000% |
-3,430,529 (Position Closed) |
Filing History |
| 2021-02-16 2:56 pm Sale |
2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
WHITEBOX ADVISORS LLC | 1,276,152 1.200% |
-3,237,834 (-71.73%) |
Filing History |
| 2021-02-16 1:45 pm Sale |
2021-02-16 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
Capital World Investors | 0 0.000% |
-3,443,000 (Position Closed) |
Filing History |
| 2021-02-12 4:21 pm Purchase |
2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 9,908,240 8.740% |
5,354,172 (+117.57%) |
Filing History |
| 2021-02-11 2:38 pm Unchanged |
2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
STATE STREET CORP STT |
14,535,872 16.460% |
0 (Unchanged) |
Filing History |
| 2021-02-10 10:46 am Purchase |
2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
The Vanguard Group | 6,387,554 7.230% |
2,169,210 (+51.42%) |
Filing History |